Browsing Category
Pharma Industry News
4743 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Theravance completes enrollment in Phase 3 CYPRESS trial for ampreloxetine in MSA-related nOH
Theravance completes Phase 3 enrollment for ampreloxetine in MSA-related nOH. Topline data expected in Q1 2026. Could this be a rare disease breakthrough?
Coya Therapeutics gets FDA green light for Phase 2 ALS trial with COYA 302
Coya Therapeutics receives FDA clearance to initiate a Phase 2 trial of COYA 302 for ALS. Find out what this means for investors and the ALS drug pipeline.
AbbVie’s $1.2bn bet on Gilgamesh’s bretisilocin signals a bold push into next-generation antidepressants
AbbVie to acquire Gilgamesh’s bretisilocin for up to $1.2B to expand its psychiatry pipeline. Find out how this short-acting psychedelic could reshape MDD care.
Healgen drug testing goes fully digital as Neopharma Technologies and Orient Gene promise tamper-proof results in minutes
Neopharma and Orient Gene digitize Healgen drug tests with NEOVAULT, bringing tamper-proof, real-time compliance and analytics to global drug testing.
Argent Biopharma (ASX: RGT) shares rise 7.69% as U.S. in vivo study validates ArtemiC efficacy in Alzheimer’s model
Argent Biopharma gains 7.69% after U.S. in vivo Alzheimer’s study validates ArtemiC’s plaque-reducing effects. Read more on RGT’s strategy and market outlook.
Innovent Biologics secures FDA greenlight for first global Phase 3 trial of IBI363 in lung cancer
Innovent Biologics wins FDA approval for its first global Phase 3 trial of IBI363 in lung cancer, signaling a major milestone in immuno-oncology.
Bio-Thera extends partnership with STADA to bring tocilizumab biosimilar across Europe
Bio-Thera and STADA extend alliance to bring tocilizumab biosimilar across Europe, expanding immunology access and reshaping the biosimilars market.
Citius Oncology bets on AI-powered sales strategy to fast-track LYMPHIR cancer drug launch
Citius Oncology launches an AI-powered platform to boost LYMPHIR’s commercial debut in CTCL, reshaping oncology sales strategies with precision targeting.
Altasciences partners with Steel Therapeutics to advance Fizurex pivotal toxicology study
Altasciences partners with Steel Therapeutics to launch a pivotal toxicology study for Fizurex, advancing FDA approval plans for this novel anal fissure therapy.
KROMATID secures $8m Series C funding to accelerate genomic structural analysis and gene therapy partnerships
KROMATID raises $8M Series C to expand genomic structural analysis and gene therapy partnerships. Find out how this growth could reshape biotech.